ABA prior authorization no timely decision means the team should pause duplicate work, preserve the notice, and identify the exact payer, product, service, reason, source, deadline, and authorized route. Diagnose whether the issue is a factual error, missing evidence, clinical disagreement, provider state, benefit rule, or timing problem. Repair only supported gaps, keep clinical decisions with qualified professionals, and follow the member's current notice rather than a generic appeal timeline.

Start with the exact notice language

ABA prior authorization no timely decision usually appears when the notice conveys this problem: A request remains unresolved after the team believes the governing decision period expired. Copy the reason exactly. Record the issuing entity, payer product, member, service, request identifier, decision date, delivery date, effective date, cited source, reviewer type when stated, appeal route, and every deadline. Normalize the case to “no timely authorization decision” for reporting while preserving the original wording beside it.

Keep authorization and payment states separate

For a case classified as “no timely authorization decision,” HealthCare.gov defines preauthorization as a plan decision about medical necessity and warns that it does not promise coverage of cost. An intake acceptance, clinical recommendation, authorization, network record, clean-claim status, adjudication, and payment each answer a different question. The denial worklist should show each state without converting one into another.

Diagnose the reason before choosing a route

For this reason, verify payer class and product, non-drug service scope, receipt event, standard or expedited class, completeness disputes, extension notice, elapsed-time calculation, status contacts, and current legal or contract source. Compare the notice with the source packet and payer record. Label confirmed facts, disputed facts, missing evidence, and unanswered questions. A phone statement can guide the next step; request written clarification when the route, criteria, deadline, or required evidence remains unclear.

Repair only the supported gap

Escalate through the payer's named channel with the receipt and clock evidence, request the written status or adverse action, and use the appeal, grievance, regulator, or contract route that applies. For Medicaid managed care, 42 CFR 438.404 treats a missed service-authorization timeframe as an adverse benefit determination on the expiration date. Other payer classes need their own rule. Keep the initial submission, payer response, corrected material, author, timestamps, reason for change, and new receipt together. The audit trail should let a reviewer reconstruct what the payer saw at each decision point.

Use program-specific appeal rules carefully

When “no timely authorization decision” is the normalized reason, CMS's current FAQ page limits CMS-0057-F requirements to named impacted payer classes. Its fact sheet requires a specific reason for covered non-drug prior-authorization denials beginning in 2026. Other commercial and employer products may follow different federal, state, plan, or contract procedures. Build the deadline from the actual notice and governing source.

Medicaid managed-care notices have defined content

If this “no timely authorization decision” case is within Medicaid managed care, 42 CFR 438.404 defines the required notice. The MCO, PIHP, or PAHP must explain the adverse benefit determination, reasons, access to relevant records and criteria, appeal and State fair-hearing rights, expedited circumstances, and continuation information. The rule also treats a missed service-authorization decision timeframe as an adverse benefit determination.

Prepare a complete appeal record

For an applicable Medicaid managed-care appeal involving “no timely authorization decision,” 42 CFR 438.406 requires reasonable assistance, acknowledgment, an appropriately qualified decision-maker for clinical issues, consideration of submitted information, and access to the case file. The clinician supplies accurate clinical analysis within scope. The enrollee or authorized representative controls the appeal choice, supported by operations and counsel as appropriate.

Check continuity conditions immediately

When “no timely authorization decision” affects ongoing care, 42 CFR 438.420 creates a narrow continued-benefit path for certain Medicaid managed-care reductions, suspensions, or terminations of previously authorized services. It has timing and eligibility conditions and possible cost recovery. Read the member's notice and current state policy at once. A general desire for continuity cannot substitute for those requirements.

Protect authority and communication

Throughout a “no timely authorization decision” review, HHS personal-representative guidance says applicable law determines who may act and the scope of that authority. ASHA's AAC portal says AAC users should always have their tools or devices. Give the person an accessible explanation and a way to participate, ask questions, assent or dissent when applicable, and express urgent health or safety concerns.

A fictional denial audit

Zora's team locks 29 notice, evidence, source, route, deadline, clinical, access, and continuity controls for one payer escalation desk case. 21 are complete, so record readiness is 21 of 29, or 72.4%. Every required control stays in the denominator. The result measures file readiness rather than approval likelihood, medical necessity, legal merit, service quality, or outcome.

Measure the reason-specific workflow

For “no timely authorization decision,” report notices classified within target divided by notices due; cases with the governing route and deadline documented divided by mature cases reviewed; complete evidence packets divided by packets due; and final dispositions reconciled divided by resolved cases. Show open cases by age and reason. Keep resubmissions, peer discussions, appeals, grievances, hearings, and claims in separate cohorts.

Related resources

Sources